CTL Fiscal Year 2024 Facts & Figures

 CTL works diligently with Cornell researchers and innovators by bringing their inventions from the lab to the marketplace. As Cornell’s technology commercialization office, we are exploring new ways to create business opportunities, launching new ventures, and helping to commercialize Cornell technologies. Learn more about CTL’s annual activities and metrics.

Commercializing

109
Licenses & Options

FY2020-2024:
477 Licenses & Options

$22 M
Revenue Generated

FY2020-2024:
$122M Revenue Generated

Venturing

10
New Startups Based on Cornell IP
$418.6 M
Funding Raised by Startups in FY24

Cornell Tech Runway:

  • Neuralenz
  • Kubbly
  • BiaWear

Cornell-licensed Startups:

  • Anova Biomedical
  • Astoria Biologica
  • Carbon to Stone
  • ExoPower
  • Giant Biosystems
  • Graphenode
  • Sacyl Pharmaceuticals

FY2020-2024:
$2.3B Funding Raised by Startups

Accelerating

23
Ignite Gap Funding Projects
Ignite Impact
$180.9 M
Follow-on Funding

Protecting

169
US Non-Provisional Patent Applications
Filed Location 2020 2021 2022 2023 2024
U.S. Provisional 158 163 163 164 143
U.S. Nonprovisional 195 179 164 169 169
International 322 304 318 217 251
Total 675 646 645 550 544
107
US Issued Patents
FY 2020 2021 2022 2023 2024
U.S. 124 127 79 104 107
International 284 191 142 117 144
Total 408 318 221 221 251

Ideating

Panelists during the "Building Bridges from Scientific Discovery to Societal Impact"
34
Educational Programs Offered
Two people talking in front of posters
70
Office Hours
Minglin Ma encapsulation device for type 1 diabetes
313
IP Disclosures

Recent News

Ignite Fellow for New Ventures

Cornell Ignite fellows bring lab discoveries closer to market impact  

| News Ignite | No Comments
Three new research projects — a treatment for childhood ear infections, an AI-powered tool to link databases and a novel gene editing method for therapeutics — will receive funding and…

Blockchain platform securely digitizes public records 

| Commercialization, News | No Comments
Ava Labs, a Cornell-licensed startup and global leader in blockchain technology, is powering the largest deed tokenization project in U.S. history. Through a partnership with Balcony, a real estate infrastructure…

Cornell-licensed startup Bactana acquired by Kemin Industries to accelerate global impact in animal health 

| Commercialization, News | No Comments
Bactana Corp., a Cornell-licensed biotechnology startup developing postbiotic solutions to improve intestinal and metabolic health, has been acquired by global ingredient manufacturer Kemin Industries. The acquisition positions Bactana to expand…

Cornell-licensed Ecolectro partners with Re:Build Manufacturing to expand renewable hydrogen production 

| Commercialization, News | No Comments
Ecolectro, a Cornell-licensed startup advancing clean energy innovation, has announced a strategic partnership with Re:Build Manufacturing to scale production of its breakthrough anion exchange membrane (AEM) electrolyzers. The collaboration will…